JP2025512098A5 - - Google Patents
Info
- Publication number
- JP2025512098A5 JP2025512098A5 JP2024560594A JP2024560594A JP2025512098A5 JP 2025512098 A5 JP2025512098 A5 JP 2025512098A5 JP 2024560594 A JP2024560594 A JP 2024560594A JP 2024560594 A JP2024560594 A JP 2024560594A JP 2025512098 A5 JP2025512098 A5 JP 2025512098A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ring
- substituted
- membered
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2022/053399 WO2023199091A1 (en) | 2022-04-12 | 2022-04-12 | Heterocyclic compound |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025512098A JP2025512098A (ja) | 2025-04-16 |
| JP2025512098A5 true JP2025512098A5 (cg-RX-API-DMAC7.html) | 2025-04-23 |
| JP7862600B2 JP7862600B2 (ja) | 2026-05-19 |
Family
ID=81749305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560594A Active JP7862600B2 (ja) | 2022-04-12 | 2022-04-12 | 複素環化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250250230A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4508027A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7862600B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023199091A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
| WO2025229495A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| WO2025229494A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1194449B1 (en) | 1999-06-28 | 2010-09-22 | Oklahoma Medical Research Foundation | Inhibitors of memapsin 2 and use thereof |
| CA2549598A1 (en) * | 2003-12-15 | 2005-06-30 | Japan Tobacco Inc. | N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| BRPI0815591B8 (pt) * | 2007-08-22 | 2021-05-25 | Astrazeneca Ab | composto, composição farmacêutica, e, uso de um composto. |
| US9527807B2 (en) | 2011-04-05 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
| US20160250224A1 (en) | 2013-09-24 | 2016-09-01 | The Board Of Regents Of The University Of Texas System | Orexin-control of bone formation and loss |
| WO2015073707A1 (en) | 2013-11-15 | 2015-05-21 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating heart failure with agonists of hypocretin receptor 2 |
| JP6552117B2 (ja) | 2014-03-28 | 2019-07-31 | 国立大学法人 筑波大学 | 敗血症の予防治療剤 |
| SG11201806429PA (en) | 2016-02-04 | 2018-08-30 | Takeda Pharmaceuticals Co | Substituted piperidine compound and use thereof |
| JP7012703B2 (ja) | 2017-03-08 | 2022-02-14 | 武田薬品工業株式会社 | 置換ピロリジン化合物およびその用途 |
| JP6957598B2 (ja) * | 2017-03-08 | 2021-11-02 | 武田薬品工業株式会社 | 置換ピロリジン化合物およびその用途 |
| US11319286B2 (en) | 2017-08-03 | 2022-05-03 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and application thereof |
| US10428023B2 (en) | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| US11655241B2 (en) | 2018-06-29 | 2023-05-23 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| EP3816154B1 (en) | 2018-06-29 | 2025-04-23 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and application thereof |
| JP7379374B2 (ja) | 2018-12-12 | 2023-11-14 | 武田薬品工業株式会社 | 複素環化合物 |
| JP7408569B2 (ja) | 2018-12-12 | 2024-01-05 | 武田薬品工業株式会社 | 複素環化合物 |
| PE20211700A1 (es) | 2019-01-31 | 2021-09-01 | Takeda Pharmaceuticals Co | Compuesto heterociclico y su uso |
| US11098029B2 (en) | 2019-02-13 | 2021-08-24 | Merck Sharp & Dohme Corp. | 5-alkyl pyrrolidine orexin receptor agonists |
| WO2020167701A1 (en) | 2019-02-13 | 2020-08-20 | Merck Sharp & Dohme Corp. | Pyrrolidine orexin receptor agonists |
| JP7172813B2 (ja) | 2019-04-09 | 2022-11-16 | 中西金属工業株式会社 | 吊車 |
| WO2021106975A1 (ja) | 2019-11-27 | 2021-06-03 | 武田薬品工業株式会社 | 複素環化合物 |
| JP2022064180A (ja) * | 2020-10-13 | 2022-04-25 | 武田薬品工業株式会社 | 複素環化合物 |
-
2022
- 2022-04-12 US US18/855,917 patent/US20250250230A1/en active Pending
- 2022-04-12 WO PCT/IB2022/053399 patent/WO2023199091A1/en not_active Ceased
- 2022-04-12 EP EP22724479.5A patent/EP4508027A1/en active Pending
- 2022-04-12 JP JP2024560594A patent/JP7862600B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023529354A5 (cg-RX-API-DMAC7.html) | ||
| JP2020510010A5 (cg-RX-API-DMAC7.html) | ||
| RU2015136770A (ru) | Хинолинамиды и хиназолинамиды в качестве модуляторов натриевых каналов | |
| FI3743406T3 (fi) | Tmem16a-modulaattoreita | |
| JP2021512143A5 (cg-RX-API-DMAC7.html) | ||
| JP2016506964A5 (ja) | ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド | |
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| RU2007142336A (ru) | Арилалкилзамещенные производные кислот и их применение | |
| JP2016506963A5 (cg-RX-API-DMAC7.html) | ||
| RU2010107892A (ru) | Производные феноксипирролидина, их применение и фармацевтические композиции, содержащие их | |
| JP2003506348A (ja) | Ccr−3受容体のインヒビターとしての尿素誘導体 | |
| JP2021530513A5 (cg-RX-API-DMAC7.html) | ||
| JP2021102643A5 (cg-RX-API-DMAC7.html) | ||
| JP2024516826A5 (cg-RX-API-DMAC7.html) | ||
| RU2018111072A (ru) | Гетероарильные соединения и их применение в качестве терапевтических лекарственных средств | |
| JP2016516028A5 (cg-RX-API-DMAC7.html) | ||
| JP2024517861A5 (cg-RX-API-DMAC7.html) | ||
| JP2019529460A5 (cg-RX-API-DMAC7.html) | ||
| JP2023525359A5 (cg-RX-API-DMAC7.html) | ||
| JP2025508359A5 (cg-RX-API-DMAC7.html) | ||
| RU2007116987A (ru) | Новые соединения | |
| JP2022527618A5 (cg-RX-API-DMAC7.html) | ||
| RU2008152404A (ru) | Лечение болевых расстройств транс 4-(3, 4-дихлорфенил)-1, 2, 3, 4-тетрагидро-1-нафталинамином и его формамидом | |
| US10647679B2 (en) | N-methyl-D-aspartate receptor (NMDAR) potentiators, pharmaceutical compositions, and uses related thereto | |
| JP2003518022A5 (cg-RX-API-DMAC7.html) |